Katrine Bosley, President and CEO at Editas Medicine, Inc. (EDIT), sold 29,490 shares at $35.04 ($1.0M) on 2018-01-03, disclosed to the SEC on 2018-01-04.
Open-market sale of $1.0M EDIT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.25 | 500 | $16K | 1.5% |
| 2 | $32.01 | 1,703 | $55K | 5.4% |
| 3 | $32.01 | 1,703 | $55K | 5.4% |
| 4 | $33.63 | 2,193 | $74K | 7.3% |
| 5 | $33.63 | 2,193 | $74K | 7.3% |
| 6 | $34.23 | 3,937 |
| $135K |
| 13.4% |
| 7 | $34.23 | 3,937 | $135K | 13.4% |
| 8 | $35.04 | 6,662 | $233K | 23.1% |
| 9 | $35.04 | 6,662 | $233K | 23.1% |
| Total | $34.20 avg | 29,490 | $1.0M | 100% |
| Filing → |
| EDIT | SELL | 2018-11-05 | $323K | — | Filing → |
| EDIT | SELL | 2018-10-03 | $745K | — | Filing → |
| EDIT | SELL | 2018-09-06 | $736K | — | Filing → |